Quantitative measurement of cartilage morphology in osteoarthritis: current knowledge and future directions

Quantitative measures of cartilage morphology (cartilage morphometry) extracted from high resolution 3D magnetic resonance imaging (MRI) sequences have been shown to be sensitive to osteoarthritis (OA)-related change and also to treatment interventions. Cartilage morphometry is therefore nowadays widely used as outcome measure for observational studies and randomized interventional clinical trials. The objective of this narrative review is to summarize the current status of cartilage morphometry in OA research, to provide insights into aspects relevant for the design of future studies and clinical trials, and to give an outlook on future developments. It covers the aspects related to the acquisition of MRIs suitable for cartilage morphometry, the analysis techniques needed for deriving quantitative measures from the MRIs, the quality assurance required for providing reliable cartilage measures, and the appropriate participant recruitment criteria for the enrichment of study cohorts with knees likely to show structural progression. Finally, it provides an overview over recent clinical trials that relied on cartilage morphometry as a structural outcome measure for evaluating the efficacy of disease-modifying OA drugs (DMOAD).

Automated summary

This review summarizes the current status of cartilage morphometry in osteoarthritis research, providing insights into future study design and clinical trials. It covers aspects related to acquiring suitable MRI images for cartilage morphometry, analyzing techniques for deriving quantitative measures, quality assurance for reliable cartilage measurement, and appropriate participant recruitment criteria.